The store will not work correctly when cookies are disabled.
4-(2-Amino-7H-pyrrol[2,3-d]pyrimidin-4-yl)benzenesulfonamide
ID: ALA4096206
PubChem CID: 137655282
Max Phase: Preclinical
Molecular Formula: C12H11N5O2S
Molecular Weight: 289.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(-c2ccc(S(N)(=O)=O)cc2)c2cc[nH]c2n1
Standard InChI: InChI=1S/C12H11N5O2S/c13-12-16-10(9-5-6-15-11(9)17-12)7-1-3-8(4-2-7)20(14,18)19/h1-6H,(H2,14,18,19)(H3,13,15,16,17)
Standard InChI Key: QBMBJIHEDJOOIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
26.9343 -1.4899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7515 -1.4941 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.3465 -0.7843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0608 -5.1714 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0597 -5.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7677 -6.3999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7659 -4.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4746 -5.1678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4793 -5.9864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2594 -6.2348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7367 -5.5697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2516 -4.9103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3516 -6.3990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7607 -3.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4688 -3.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4667 -2.7216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7572 -2.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0484 -2.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0540 -3.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4597 -1.0855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
7 14 1 0
17 2 1 0
2 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.32 | Molecular Weight (Monoisotopic): 289.0633 | AlogP: 0.85 | #Rotatable Bonds: 2 |
Polar Surface Area: 127.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.05 | CX Basic pKa: 6.42 | CX LogP: 1.00 | CX LogD: 0.96 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.64 | Np Likeness Score: -1.11 |
References
1. Anthony NG, Baiget J, Berretta G, Boyd M, Breen D, Edwards J, Gamble C, Gray AI, Harvey AL, Hatziieremia S, Ho KH, Huggan JK, Lang S, Llona-Minguez S, Luo JL, McIntosh K, Paul A, Plevin RJ, Robertson MN, Scott R, Suckling CJ, Sutcliffe OB, Young LC, Mackay SP.. (2017) Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers., 60 (16): [PMID:28737909] [10.1021/acs.jmedchem.7b00484] |